Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00210288
Status:
COMPLETED
Last Update Posted:
2018-08-08
First Post:
2005-09-13
Brief Title:
Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine
Sponsor:
Institut Pasteur
Organization:
Institut Pasteur
Study Overview
Official Title:
A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of Two Doses 105 and 107 CFU of SC599 Oral Vaccine a Live Attenuated Shigella Dysenteriae 1 Vaccine Strain in Healthy Human Adult Volunteers
Status:
COMPLETED
Status Verified Date:
2010-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the immune response produced by two doses of SC599 vaccine compared to placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None